Küster, M. M., Schneider, M. A., Richter, A. M., Richtmann, S., Winter, H., Kriegsmann, M., . . . Dammann, R. H. (2020). Epigenetic Inactivation of the Tumor Suppressor IRX1 Occurs Frequently in Lung Adenocarcinoma and Its Silencing Is Associated with Impaired Prognosis. Cancers (Basel).
Citação norma ChicagoKüster, Miriam M., et al. "Epigenetic Inactivation of the Tumor Suppressor IRX1 Occurs Frequently in Lung Adenocarcinoma and Its Silencing Is Associated With Impaired Prognosis." Cancers (Basel) 2020.
Citação norma MLAKüster, Miriam M., et al. "Epigenetic Inactivation of the Tumor Suppressor IRX1 Occurs Frequently in Lung Adenocarcinoma and Its Silencing Is Associated With Impaired Prognosis." Cancers (Basel) 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.